BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34216315)

  • 21. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome.
    Petrikova J; Lazurova I; Dravecka I; Vrbikova J; Kozakova D; Figurova J; Vaczy Z; Rosocha J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):302-6. PubMed ID: 25485530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls.
    Kim JJ; Yoon JW; Kim MJ; Kim SM; Hwang KR; Choi YM
    Hum Fertil (Camb); 2022 Feb; 25(1):128-134. PubMed ID: 31910041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
    Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.
    Moro F; Tropea A; Scarinci E; Federico A; De Simone C; Caldarola G; Leoncini E; Boccia S; Lanzone A; Apa R
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():101-5. PubMed ID: 26115053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome and (pre)osteoarthritis: assessing the link between hyperandrogenism in young women and cartilage oligomeric matrix protein as a marker of cartilage breakdown.
    Kabakchieva P; Georgiev T; Gateva A; Hristova J; Kamenov Z
    Clin Rheumatol; 2021 Oct; 40(10):4217-4223. PubMed ID: 33948768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Body composition and polycystic ovary syndrome].
    Zabuliene L; Tutkuviene J
    Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.
    Carmina E; Napoli N; Longo RA; Rini GB; Lobo RA
    Eur J Endocrinol; 2006 Jan; 154(1):141-5. PubMed ID: 16382003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.